» Articles » PMID: 33875803

Amplification-free RNA Detection with CRISPR-Cas13

Overview
Journal Commun Biol
Specialty Biology
Date 2021 Apr 20
PMID 33875803
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR-based nucleic-acid detection is an emerging technology for molecular diagnostics. However, these methods generally require several hours and could cause amplification errors, due to the pre-amplification of target nucleic acids to enhance the detection sensitivity. Here, we developed a platform that allows "CRISPR-based amplification-free digital RNA detection (SATORI)", by combining CRISPR-Cas13-based RNA detection and microchamber-array technologies. SATORI detected single-stranded RNA targets with maximal sensitivity of ~10 fM in <5 min, with high specificity. Furthermore, the simultaneous use of multiple different guide RNAs enhanced the sensitivity, thereby enabling the detection of the SARS-CoV-2 N-gene RNA at ~5 fM levels. Therefore, we hope SATORI will serve as a powerful class of accurate and rapid diagnostics.

Citing Articles

Building the Future of Clinical Diagnostics: An Analysis of Potential Benefits and Current Barriers in CRISPR/Cas Diagnostics.

van Dongen J, Segerink L ACS Synth Biol. 2025; 14(2):323-331.

PMID: 39880685 PMC: 11854988. DOI: 10.1021/acssynbio.4c00816.


Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections.

Lakshmanan K, Liu B Diagnostics (Basel). 2025; 15(2).

PMID: 39857007 PMC: 11763637. DOI: 10.3390/diagnostics15020123.


A CRISPR-Cas12a-based universal rapid scrub typhus diagnostic method targeting 16S rRNA of Orientia tsutsugamushi.

Park B, Heo S, Kim M, Yoo J, Bae E, Kang S PLoS Negl Trop Dis. 2025; 19(1):e0012826.

PMID: 39841710 PMC: 11790230. DOI: 10.1371/journal.pntd.0012826.


Compact Digital Immunoassay Platform Integrating ELISA with a Lateral Flow Strip.

Degawa T, Hori Y, Orikasa M, Narita H, Komori T, Yoshimura T Biomedicines. 2024; 12(11).

PMID: 39595082 PMC: 11591789. DOI: 10.3390/biomedicines12112517.


Digital CRISPR-Powered Biosensor Concept without Target Amplification Using Single-Impact Electrochemistry.

Freko S, Nikic M, Mayer D, Weiss L, Simmel F, Wolfrum B ACS Sens. 2024; 9(11):6197-6206.

PMID: 39435883 PMC: 11590096. DOI: 10.1021/acssensors.4c02060.


References
1.
Reijns M, Thompson L, Carlos Acosta J, Black H, Sanchez-Luque F, Diamond A . A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection. PLoS Biol. 2020; 18(12):e3001030. PMC: 7771873. DOI: 10.1371/journal.pbio.3001030. View

2.
Chen J, Ma E, Harrington L, Da Costa M, Tian X, Palefsky J . CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018; 360(6387):436-439. PMC: 6628903. DOI: 10.1126/science.aar6245. View

3.
Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C . Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014; 11(8):809-15. DOI: 10.1038/nmeth.3014. View

4.
Minagawa Y, Ueno H, Tabata K, Noji H . Mobile imaging platform for digital influenza virus counting. Lab Chip. 2019; 19(16):2678-2687. DOI: 10.1039/c9lc00370c. View

5.
Vogels C, Brito A, Wyllie A, Fauver J, Ott I, Kalinich C . Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol. 2020; 5(10):1299-1305. PMC: 9241364. DOI: 10.1038/s41564-020-0761-6. View